Published in J Inherit Metab Dis on January 01, 2005
Population screening in the age of genomic medicine. N Engl J Med (2003) 3.89
Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet (1995) 2.66
Broad screening test for sphingolipid-storage diseases. Lancet (1999) 1.97
Enzyme replacement and enhancement therapies: lessons from lysosomal disorders. Nat Rev Genet (2002) 1.72
Preimplantation genetic diagnosis. Nat Rev Genet (2002) 1.62
The use and abuse of filipin to localize cholesterol in membranes. Cell Biol Int Rep (1984) 1.29
Sphingomyelin hydrolysis during apoptosis. Biochim Biophys Acta (2002) 1.27
A fluorescence-based, high-performance liquid chromatographic assay to determine acid sphingomyelinase activity and diagnose types A and B Niemann-Pick disease. Anal Biochem (2003) 1.23
Lipid domains in the membrane: thermotropic properties of sphingomyelin vesicles containing GM1 ganglioside and cholesterol. Biochemistry (1997) 1.11
Use of BODIPY-labeled sphingolipids to study membrane traffic along the endocytic pathway. Ann N Y Acad Sci (1998) 1.05
Reproductive pathology and sperm physiology in acid sphingomyelinase-deficient mice. Am J Pathol (2002) 1.00
Insights into the diagnosis and treatment of lysosomal storage diseases. Arch Neurol (2003) 0.98
Acid sphingomyelinase-derived ceramide signaling in apoptosis. Subcell Biochem (2002) 0.97
Lysosomal storage disorders: diagnostic dilemmas and prospects for therapy. Genet Med (2003) 0.93
Fluorescence-based selection of retrovirally transduced cells in the absence of a marker gene: direct selection of transduced type B Niemann-Pick disease cells and evidence for bystander correction. Hum Gene Ther (1995) 0.85
Neutral magnesium-dependent sphingomyelinase from liver plasma membrane: purification and inhibition by ubiquinol. J Bioenerg Biomembr (2001) 0.85
Isolation and characterization of sea urchin egg lipid rafts and their possible function during fertilization. Mol Reprod Dev (2001) 0.84
Membrane organization in the preimplantation mouse embryo. J Embryol Exp Morphol (1985) 0.83
Expression of beta-galactosidase in preimplantation ovine and porcine embryos. Proc Soc Exp Biol Med (1990) 0.81
Intracellular degradation of fluorescent glycolipids by lysosomal enzymes and their activators. J Inherit Metab Dis (1999) 0.80
New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases. Adv Exp Med Biol (2003) 0.80
Beta-N-acetylhexosaminidase activity in human oocytes and preimplantation embryos. Hum Reprod (1992) 0.78
Beta-N-acetylhexosaminidase activity in mouse oocytes and preimplantation embryos. Hum Reprod (1991) 0.78
Beta-glucuronidase activity in mouse oocytes, mouse preimplantation embryos, and human gametes. Prenat Diagn (1991) 0.77
Diagnosing sphingolipidoses in murine and human embryos. Hum Reprod (1993) 0.77
Primer system for single cell detection of double mutation for Tay-Sachs disease. J Assist Reprod Genet (2000) 0.75
Some strains in search of a genus--Corynebacterium, Mycobacterium, Nocardia or what? J Gen Microbiol (1966) 5.08
Dynamic organization of DNA replication in mammalian cell nuclei: spatially and temporally defined replication of chromosome-specific alpha-satellite DNA sequences. J Cell Biol (1992) 4.39
The presynaptic particle web: ultrastructure, composition, dissolution, and reconstitution. Neuron (2001) 3.68
New techniques for imaging, digitization and analysis of three-dimensional neural morphology on multiple scales. Neuroscience (2005) 3.06
Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med (2000) 2.96
Identification of nocardiae and streptomycetes of medical importance. J Clin Microbiol (1980) 2.87
Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet (1995) 2.66
Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell (1996) 2.66
A co-operative numerical analysis of rapidly growing mycobacteria. J Gen Microbiol (1972) 2.63
Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol (2000) 2.57
Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg (1998) 2.24
Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med (1997) 2.21
A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies. Am J Hum Genet (2001) 2.13
The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression. Genomics (1999) 2.04
Clinical use of nuclear magnetic resonance in the investigation of myopathy. Lancet (1982) 2.02
Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med (1985) 1.83
Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem (1996) 1.78
Ethanol up-regulates fatty acid uptake and plasma membrane expression and export of mitochondrial aspartate aminotransferase in HepG2 cells. Hepatology (1998) 1.72
Isolation of beta-N-acetylhexosaminidase, beta-N-acetylglucosaminidase, and beta-N-acetylgalactosaminidase from calf brain. Biochemistry (1967) 1.69
In vivo carbon-13 nuclear magnetic resonance studies of mammals. Science (1981) 1.61
Some criteria for the recognition of Nocardia madurae (Vincent) Blanchard. J Gen Microbiol (1966) 1.61
The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J Biol Chem (1998) 1.57
Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts. EMBO J (1989) 1.55
Radiographic detection of strut separations in Björk-Shiley convexo-concave mitral valves. N Engl J Med (1995) 1.55
Paneth cell-like metaplasia of the prostate gland. Arch Pathol Lab Med (1992) 1.51
Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification Of the first molecular lesion causing Farber disease. J Biol Chem (1996) 1.49
Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice. Am J Hum Genet (2000) 1.48
Avoiding palatopharyngeal trauma during videolaryngoscopy: do not forget the 'blind spots'. Acta Anaesthesiol Scand (2012) 1.47
Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. J Biol Chem (2000) 1.45
Regional assignment of the human acid sphingomyelinase gene (SMPD1) by PCR analysis of somatic cell hybrids and in situ hybridization to 11p15.1----p15.4. Genomics (1991) 1.43
High-order structure and dissociation of gaseous peptide aggregates that are hidden in mass spectra. J Am Soc Mass Spectrom (1998) 1.41
The role of the family physician in the day care setting. Am Fam Physician (1996) 1.38
Derivation and prospective testing of a two-step sevoflurane-O2-N2O low fresh gas flow sequence. Anaesth Intensive Care (2009) 1.38
Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges. Annu Rev Genomics Hum Genet (2012) 1.37
Some bits and pieces of the genus Nocardia: N. carnea, N. vaccinii, N. transvalensis, N. orientalis and N. aerocolonigenes. J Gen Microbiol (1978) 1.35
Polysaccharides of the genus Bacillus cross-reactive with the capsular polysaccharides of Diplococcus pneumoniae type 3, Haemophilus influenzae type b, and Neisseria meningitidis group A. Infect Immun (1973) 1.34
Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease. Crit Rev Biochem Mol Biol (1990) 1.32
Localization of metabolites in animals using 31P topical magnetic resonance. Nature (1980) 1.32
Niemann-Pick type B disease. Identification of a single codon deletion in the acid sphingomyelinase gene and genotype/phenotype correlations in type A and B patients. J Clin Invest (1991) 1.32
A freeze fracture study of Crohn's disease of the terminal ileum: changes in epithelial tight junction organization. Am J Gastroenterol (1983) 1.32
Isolation of beta-galactosidase and beta-glucosidase from brain. Biochim Biophys Acta (1966) 1.31
Characterization of human acid sphingomyelinase purified from the media of overexpressing Chinese hamster ovary cells. Biochim Biophys Acta (1999) 1.30
Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: correlation with leukocyte recruitment to adherent platelets 1 hour after injury. Circulation (2001) 1.27
Niemann-Pick disease: a frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients. Proc Natl Acad Sci U S A (1991) 1.25
Purification and separation of alpha- and beta-galactosidases from spinach leaves. Biochim Biophys Acta (1970) 1.24
Purification, characterization, and biosynthesis of human acid ceramidase. J Biol Chem (1995) 1.23
Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J Mol Neurosci (2000) 1.22
Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients. Am J Med Genet (1985) 1.21
Localization of factor-VIII-related antigen in human vascular subendothelium. Blood (1980) 1.20
31P-NMR investigation of solid tumours in the living rat. Biosci Rep (1981) 1.20
Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site. Proc Natl Acad Sci U S A (1986) 1.20
Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: clinical, morphologic, and biochemical studies of nine cases. Neurology (1981) 1.18
Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation. Am J Pathol (2001) 1.18
Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine. Am J Hum Genet (1985) 1.17
Preparation and characterization of well defined D-erythro sphingomyelins. Chem Phys Lipids (1984) 1.16
Cloning and characterization of the full-length cDNA and genomic sequences encoding murine acid ceramidase. Genomics (1998) 1.15
Enzymes of complex lipid metabolism. Annu Rev Biochem (1973) 1.14
Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by retroviral vector-mediated gene transfer. Proc Natl Acad Sci U S A (1990) 1.14
Isolation of rat brain lecithinase-A, specific for the alpha'-position of lecithin. Biochem Biophys Res Commun (1966) 1.13
Enzymatic hydrolysis of sphingolipids. II. Hydrolysis of sphingomyelin by an enzyme from rat brain. J Biol Chem (1966) 1.12
The relationship between perineal cosmetic talc usage and ovarian talc particle burden. Am J Obstet Gynecol (1996) 1.12
Ultrasound findings of renal angiomyolipoma. J Clin Ultrasound (1978) 1.12
A piecemeal description of Streptomyces griseus (Krainsky) Waksman and Henrici. J Gen Microbiol (1968) 1.11
JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure. Cell Death Dis (2012) 1.11
Antimalarial activities of dermaseptin S4 derivatives. Antimicrob Agents Chemother (2000) 1.10
A spectrophotometric method for determination of sphingomyelinase. Biochim Biophys Acta (1978) 1.10
Correlation of asbestos fiber burdens in fallopian tubes and ovarian tissue. Am J Obstet Gynecol (1999) 1.10
31P NMR studies of resting muscle in normal human subjects. Adv Exp Med Biol (1984) 1.08
Breast disorders in nursing mothers. Am Fam Physician (1990) 1.08
Infusion of recombinant human acid sphingomyelinase into niemann-pick disease mice leads to visceral, but not neurological, correction of the pathophysiology. FASEB J (2000) 1.07
Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes. J Biol Chem (1986) 1.07
Identification and expression of a common missense mutation (L302P) in the acid sphingomyelinase gene of Ashkenazi Jewish type A Niemann-Pick disease patients. Blood (1992) 1.07
Sphingomyelin suppresses the binding and utilization of low density lipoproteins by skin fibroblasts. J Biol Chem (1980) 1.06
Human acid ceramidase: processing, glycosylation, and lysosomal targeting. J Biol Chem (2001) 1.06
Expression of mutated glucocerebrosidase alleles in human cells. Hum Mol Genet (1997) 1.06
Purification and properties of phospholipase A-1 from rat and calf brain. Biochim Biophys Acta (1968) 1.05
Enzymatic hydrolysis of sphingolipids. I. Hydrolysis and synthesis of ceramides by an enzyme from rat brain. J Biol Chem (1966) 1.04
Enzymatic hydrolysis of sphingolipids. VII. Hydrolysis of gangliosides by a neuraminidase from calf brain. Biochim Biophys Acta (1968) 1.04
Identification of a ligand-dependent switch within a muscarinic receptor. J Biol Chem (1998) 1.04
Noninvasive investigation of cerebral ischemia by phosphorus nuclear magnetic resonance. Pediatrics (1982) 1.03
Gaucher type I (Ashkenazi) disease: a new method for heterozygote detection using a novel fluorescent natural substrate. Clin Chim Acta (1982) 1.02
Black beauty out of Mycobacterium fortuitum Cruz. Appl Microbiol (1970) 1.02
Role of acidic sphingomyelinase in Fas/CD95-mediated cell death. J Biol Chem (2000) 1.02
Mucopolysaccharidosis type VI in rats: isolation of cDNAs encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation. Genomics (1995) 1.01
Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res (1982) 1.01
Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate. Cancer Res (1984) 1.01
Asbestos exposure and ovarian fiber burden. Am J Ind Med (1996) 1.00
Mucopolysaccharidosis type VI: identification of three mutations in the arylsulfatase B gene of patients with the severe and mild phenotypes provides molecular evidence for genetic heterogeneity. Am J Hum Genet (1992) 1.00
Synthesis of a fluorescent derivative of glucosyl ceramide for the sensitive determination of glucocerebrosidase activity. Anal Biochem (1984) 0.99
Patterned cerebellar Purkinje cell death in a transgenic mouse model of Niemann Pick type A/B disease. Eur J Neurosci (2001) 0.99
Functional characterization of the N-glycosylation sites of human acid sphingomyelinase by site-directed mutagenesis. Eur J Biochem (1997) 0.99